| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Oct-07 | | Total Revenue | 9,015 | 7,548 | 9,686 | | Cost of Revenue | 866 | 695 | 861 | | | Gross Profit | 8,149 | 6,853 | 8,825 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 198 | 164 | 254 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,952 | 6,689 | 8,571 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,107) | (9,429) | (5,713) | | Earnings Before Interest And Taxes | 7,952 | 6,689 | 8,571 | | Interest Expense | 29 | 13 |
-
| | Income Before Tax | 7,923 | 6,676 | 8,571 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,184) | (2,753) | 2,858 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,184) | (2,753) | 2,858 | | Preferred Stock And Other Adjustments | (1,142) | (1,637) | (2,224) | | | Net Income Applicable To Common Shares | ($3,326) | ($4,390) | $635 |
|
0.51% Nasdaq 
Income Statement
